Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Free Cash Flow (2017 - 2025)

Sensus Healthcare has reported Free Cash Flow over the past 9 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$2.4 million for Q4 2025, down 346.23% from a year ago — trailing twelve months through Dec 2025 was $332000.0 (up 129.99% YoY), and the annual figure for FY2025 was $332000.0, up 129.99%.
  • Free Cash Flow for Q4 2025 was -$2.4 million at Sensus Healthcare, down from $2.3 million in the prior quarter.
  • Over the last five years, Free Cash Flow for SRTS hit a ceiling of $4.2 million in Q2 2024 and a floor of -$10.1 million in Q4 2022.
  • Median Free Cash Flow over the past 5 years was $981500.0 (2021), compared with a mean of -$256700.0.
  • Biggest five-year swings in Free Cash Flow: tumbled 499.67% in 2021 and later skyrocketed 738.98% in 2024.
  • Sensus Healthcare's Free Cash Flow stood at -$1.8 million in 2021, then crashed by 456.82% to -$10.1 million in 2022, then surged by 126.36% to $2.7 million in 2023, then plummeted by 119.87% to -$530000.0 in 2024, then plummeted by 346.23% to -$2.4 million in 2025.
  • The last three reported values for Free Cash Flow were -$2.4 million (Q4 2025), $2.3 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.